CoChat

Developing services to support the delivery of care to people with early‐onset type 2 diabetes

Open access

The DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index; none of the 64 sources its claims cite is checked for support yet.

Abstract

Early‐onset type 2 diabetes occurring in childhood or early adulthood carries a significant excess burden of microvascular diabetes complications, cardiovascular disease and premature death, compared to later onset type 2 diabetes along with adverse pregnancy outcomes in women of child‐bearing age. National audit data in England reveal that 122,780 individuals under the age of 40 years are currently living with type 2 diabetes, with an over‐representation of people from minority ethnicities and those in the most socioeconomically deprived quintiles. A diagnosis of type 2 diabetes earlier in life poses some unique challenges to healthcare providers that are not routinely encountered when type 2 diabetes presents later. These include; (1) the need to ensure correct diabetes classification in an age group that carries a higher probability of other types of diabetes, (2) overcoming difficulties in engaging with individuals who are of working age or in full‐time education, (3) appreciating and addressing the lower attainment of diabetes treatment targets and (4) proactively supporting women of child‐bearing age to optimise their future pregnancy outcomes through better preparation for pregnancy, including achieving optimum glycaemic control at the time of conception. Meanwhile, approaches to prevent type 2 diabetes in younger age groups are challenged by difficulties in identifying those at highest risk, by poorer attendance at lifestyle interventions to prevent or delay the onset of type 2 diabetes and by attenuation of associated weight loss in those that do attend. In this article, we discuss the importance of recognising and addressing the distinct challenges in delivering healthcare to those with early‐onset type 2 diabetes, the greater challenges in preventing type 2 diabetes at younger ages, and key components of strategies that might address these challenges to drive improvements in pregnancy outcomes, microvascular and cardiovascular outcomes.

Overview

CoChat Summary

TL;DR

Early-onset type 2 diabetes (diagnosis under 40 years) is a rising, high-risk condition with excess microvascular/cardiovascular complications, premature mortality, and adverse pregnancy outcomes, disproportionately affecting minority ethnic and socioeconomically deprived groups. This narrative review argues for local integrated strategies covering accurate diagnosis, engagement, prevention, care-process attainment, and primary–specialist partnership.

Key findings

  • The paper proposes defining early-onset type 2 diabetes as diagnosis under 40 years. English National Diabetes Audit data show 122,780 people under 40 with type 2 diabetes: 650 (0.5%) under 16 years, 910 (0.7%) aged 16–18, 8,245 (6.7%) aged 19–25, and 112,980 (92%) aged 26–39. Asian and Black individuals and people in the most deprived quintile are over-represented; for example, 42% of those under 16, 38% aged 16–18, 35% aged 19–25, and 35% aged 26–39 were in the most deprived quintile, versus 25% of those aged 40–79.
  • Risk is severe: average life lost is 11 years for diagnosis under 20 years and 7 years for diagnosis at 20–39 years, compared with people without diabetes. In the TODAY cohort of 500 individuals diagnosed under 20 years, after mean 13 years, cumulative incidence was diabetic kidney disease 55%, retinopathy 51%, and neuropathy 32%; hypertension was 68% and dyslipidaemia 52%. In 260 TODAY pregnancies (mean age 21.5 years, mean diabetes duration 8 years), pregnancy loss occurred in 25% and preterm birth in 33%.
  • Care and prevention gaps are marked: 33% of people with type 2 diabetes aged under 40 received all 8 care processes, versus 47% aged 40–59 and 59% aged 60–79. In NHS Diabetes Prevention Programme early outcome data, 5% of referrals (n = 17,797) were aged under 40, and completers had a mean weight reduction of 2.4 kg—the smallest of all age categories.
  • The authors recommend local strategies, a diagnostic hub for accurate classification (including autoantibody testing and MODY consideration), non-traditional engagement, skills development, prevention, and integrated primary–specialist care.

Methods

  • Narrative review/discussion article; no formal systematic review, search strategy, or primary data collection is described.
  • It synthesizes cited literature and national audit/registry data, including the English National Diabetes Audit, Clinical Practice Research Datalink, TODAY, SEARCH, and the NHS Diabetes Prevention Programme.
  • No main statistical analysis is reported; the numerical findings are drawn from the cited sources.

Limitations

  • The paper states a paucity of evidence for optimal management in adults with early-onset type 2 diabetes, no prospective studies in adults, no age-specific guideline targets, uncertainty whether poor outcomes reflect inadequate management versus intrinsic disease, and inconclusive evidence for widespread screening in younger adults.
  • It states research gaps including drug-class choice, timing of insulin, tighter targets versus BMI/weight-loss focus, remission and bariatric surgery, and ethnicity interactions.
  • Evident from the text: this is a narrative review without a systematic search, and the authors report conflicts of interest (all are members of National Diabetes Audit clinical advisory groups; some have industry ties and NHS England roles), which may shape the perspectives presented.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1111/dme.14927

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

FIGURE 1 A schematic diagram illustrating different subtypes of diabetes and their relative likelihood according to age at diagnosis. In childhood type 1 diabetes presentations (shaded blue) predominate and MODY (shaded pink) is relatively easy to identify as it is primarily being differentiated from type 1 diabetes. In adolescents and young adults, the rising prevalence of early‐onset type 2 diabetes (shaded green or grey), obscures the identification of MODY as the presentation is broadly similar, but also type 1 diabetes if the presentation is not typical. The rise in type 2 diabetes cases, the age of onset and the number of cases, varies by ethnic group, thus in an ethnic group with a high prevalence of early‐onset type 2 diabetes (shaded green), the detection of other forms may be masked to a greater extent in early adulthood, compared to an ethnic group with lower prevalence (shaded grey). MODY, maturity‐onset diabetes of the young.
FIGURE 1 A schematic diagram illustrating different subtypes of diabetes and their relative likelihood according to age at diagnosis. In childhood type 1 diabetes presentations (shaded blue) predominate and MODY (shaded pink) is relatively easy to identify as it is primarily being differentiated from type 1 diabetes. In adolescents and young adults, the rising prevalence of early‐onset type 2 diabetes (shaded green or grey), obscures the identification of MODY as the presentation is broadly similar, but also type 1 diabetes if the presentation is not typical. The rise in type 2 diabetes cases, the age of onset and the number of cases, varies by ethnic group, thus in an ethnic group with a high prevalence of early‐onset type 2 diabetes (shaded green), the detection of other forms may be masked to a greater extent in early adulthood, compared to an ethnic group with lower prevalence (shaded grey). MODY, maturity‐onset diabetes of the young.CC BY-NC-ND · PubMed Central
FIGURE 2 A schematic representation of key aspects of a model of care for those with early‐onset type 2 diabetes. A diagnosis of type 2 diabetes below 40 years could (1) prompt the consideration of specialist tests of atypical features present. Following confirmation of subtype, (2) a ‘low risk’ patient (most would be at diagnosis) could be referred to a GP with a special interest in early‐onset type 2 diabetes who has developed relevant skills. If an individual became ‘higher risk’ at any time (3) they could be referred to a community diabetes clinic with specialist input or access to a multi‐disciplinary team with further referral to secondary care services when needed. An over‐arching theme of this integrated community system would be a data‐driven approach with knowledge of numbers of the affected individuals in a geography, proportions meeting the three treatment targets and receiving the eight/nine care processes and other demographic characteristics that may warrant approaches that drive better engagement.
FIGURE 2 A schematic representation of key aspects of a model of care for those with early‐onset type 2 diabetes. A diagnosis of type 2 diabetes below 40 years could (1) prompt the consideration of specialist tests of atypical features present. Following confirmation of subtype, (2) a ‘low risk’ patient (most would be at diagnosis) could be referred to a GP with a special interest in early‐onset type 2 diabetes who has developed relevant skills. If an individual became ‘higher risk’ at any time (3) they could be referred to a community diabetes clinic with specialist input or access to a multi‐disciplinary team with further referral to secondary care services when needed. An over‐arching theme of this integrated community system would be a data‐driven approach with knowledge of numbers of the affected individuals in a geography, proportions meeting the three treatment targets and receiving the eight/nine care processes and other demographic characteristics that may warrant approaches that drive better engagement.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 40 Not checked · 12 Own results and interpretations

19 more claims

Create a free account to see all 52 claims and to verify the 62 references still open.

See all claims — free account
  • It may state two separate claims as one. 23
  • Probably not a substantial claim. 7

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

4 of 4

Citations

Cites

Research works printed but not linked: 3

  1. 10.1001/jama.297.24.2716 · DOI · Paper page
  2. Misra S, 2017, Textbook of Diabetes, 243
  3. [NG17], 2022, Type 1 diabetes in adults: diagnosis and management, NICE

Cited by

See all 23

Metadata

Authors
Misra, S., Gable, D., Khunti, K., Barron, E., Young, B., Kar, P., & Valabhji, J.
Affiliations
  • Imperial College Healthcare NHS Trust (GB)
  • University of Leicester (GB)
  • NHS England (GB)
  • Portsmouth Hospitals NHS Trust (GB)
Corresponding author
Misra, Shivani
Venue
Diabetic Medicine
Publisher
Wiley
Published
2022-08-23
Volume
39
Issue
10
Pages
e14927-e14927
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W4288447618
Cited by
23
References
61
Citations by year
2026: 7 · 2025: 7 · 2024: 4 · 2023: 3 · 2022: 2
FWCI
0.47
Type
journal article
Language
en
Open access
Locations
  • Diabetic Medicine (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
Funders
  • NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
  • Imperial College Healthcare NHS Trust
  • National Institute for Health Research
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
early-onset type 2 diabetes, young adults, diabetes care services, diabetes classification, glycemic control, pregnancy outcomes, women of child-bearing age, type 2 diabetes prevention, lifestyle intervention, ethnic minorities, socioeconomic deprivation, microvascular complications, cardiovascular risk, healthcare engagement
MeSH terms
Adult, Diabetes Mellitus, Type 2, Ethnicity, Female, Humans, Life Style, Minority Groups, Pregnancy, Pregnancy Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-20, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-20 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.